Dan S. Childs

ASCO in Real Time: Breaking Advances for Nuclear Medicine

Abstract placeholder. Drop in the official SNMMI session abstract once published.

Day and time to be confirmed against the SNMMI program.

1. What's the most overlooked piece of infrastructure in this ecosystem?
2. Which trial readout in 2026 will most reshape the field?
3. How do you separate signal from noise in imaging endpoints right now?

Generated by a mock model. Wired to Anthropic when the API key is in place.

What we're seeing

• FierceBiotech · 2026-07-18
  Dan S Childs cited in NEJM perspective on theranostic standardization
  Coverage notes the company's growing footprint in the radioligand therapy space.
• BioPharma Reporter · 2026-04-25
  Dan S Childs joins editorial board of European Journal of Nuclear Medicine
  The work builds on more than a decade of radiochemistry collaboration.
• Reuters Health · 2026-01-16
  Dan S Childs presents updated trial data at ASCO Annual Meeting
  The work builds on more than a decade of radiochemistry collaboration.
• Endpoints News · 2026-10-11
  Dan S Childs co-authors review on PSMA in Journal of Nuclear Medicine
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Nuclear Medicine Today · 2026-07-02
  Dan S Childs comments on FDA guidance for radiopharmaceutical trials
  The work builds on more than a decade of radiochemistry collaboration.

Mocked while we wire the Exa integration. Headlines are illustrative.